English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52016536    線上人數 :  818
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"weng c t"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-10 / 15 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-07-03T03:33:57Z Use of HLA-B?58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: National prospective cohort study Ko T.-M.; Tsai C.-Y.; Chen S.-Y.; Chen K.-S.; Yu K.-H.; Chu C.-S.; Huang C.-M.; Wang C.-R.; Weng C.-T.; Yu C.-L.; Hsieh S.-C.; Tsai J.-C.; Lai W.-T.; Tsai W.-C.; Yin G.-D.; Ou T.-T.; Cheng K.-H.; Yen J.-H.; Liou T.-L.; Lin T.-H.; Chen D.-Y.; Hsiao P.-J.; Weng M.-Y.; Chen Y.-M.; Chen C.-H.; Liu M.-F.; Yen H.-W.; Lee J.-J.; Kuo M.-C.; Wu C.-C.; Hung S.-Y.; Luo S.-F.; Yang Y.-H.; Chuang H.-P.; Chou Y.-C.; Liao H.-T.; Wang C.-W.; Huang C.-L.; Chang C.-S.; Lee M.-T.M.; PEI-JER CHEN; Wong C.-S.; Chen C.-H.; Wu J.-Y.; Chen Y.-T.; Shen C.-Y.
臺大學術典藏 2021-01-27T01:38:01Z Use of HLA-B∗58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: National prospective cohort study Ko T.-M.; Tsai C.-Y.; Chen S.-Y.; Chen K.-S.; Yu K.-H.; Chu C.-S.; Huang C.-M.; Wang C.-R.; Weng C.-T.; CHIA-LI YU; Hsieh S.-C.; Tsai J.-C.; Lai W.-T.; Tsai W.-C.; Yin G.-D.; Ou T.-T.; Cheng K.-H.; Yen J.-H.; Liou T.-L.; Lin T.-H.; Chen D.-Y.; Hsiao P.-J.; Weng M.-Y.; Chen Y.-M.; Chen C.-H.; Liu M.-F.; Yen H.-W.; Lee J.-J.; Kuo M.-C.; Wu C.-C.; Hung S.-Y.; Luo S.-F.; Yang Y.-H.; Chuang H.-P.; Chou Y.-C.; Liao H.-T.; Wang C.-W.; Huang C.-L.; Chang C.-S.; Lee M.-T.M.; Chen P.; Wong C.-S.; Chen C.-H.; Wu J.-Y.; Chen Y.-T.; Shen C.-Y.
臺大學術典藏 2021-01-15T02:46:21Z Use of HLA-B∗58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: National prospective cohort study Ko T.-M.; Tsai C.-Y.; Chen S.-Y.; Chen K.-S.; Yu K.-H.; Chu C.-S.; Huang C.-M.; Wang C.-R.; Weng C.-T.; Yu C.-L.; SONG-CHOU HSIEH; Tsai J.-C.; Lai W.-T.; Tsai W.-C.; Yin G.-D.; Ou T.-T.; Cheng K.-H.; Yen J.-H.; Liou T.-L.; Lin T.-H.; Chen D.-Y.; Hsiao P.-J.; Weng M.-Y.; Chen Y.-M.; Chen C.-H.; Liu M.-F.; Yen H.-W.; Lee J.-J.; Kuo M.-C.; Wu C.-C.; Hung S.-Y.; Luo S.-F.; Yang Y.-H.; Chuang H.-P.; Chou Y.-C.; Liao H.-T.; Wang C.-W.; Huang C.-L.; Chang C.-S.; Lee M.-T.M.; Chen P.; Wong C.-S.; Chen C.-H.; Wu J.-Y.; Chen Y.-T.; Shen C.-Y.
臺大學術典藏 2020-02-10T05:32:18Z AnyButton: Unpowered, modeless and highly available mobile input using unmodified clothing buttons Chan, L;Weng, C.-T;Liang, R.-H.;Chen, B.-Y.; Chan, L; Weng, C.-T; Liang, R.-H; Chen, B.-Y.; BING-YU CHEN
臺大學術典藏 2018-09-10T09:46:10Z NailDisplay: Bringing an always-available visual display to fingertips Su, C.-H.;Chan, L.;Weng, C.-T.;Liang, R.-H.;Cheng, K.-Y.;Chen, B.-Y.; Su, C.-H.; Chan, L.; Weng, C.-T.; Liang, R.-H.; Cheng, K.-Y.; Chen, B.-Y.; BING-YU CHEN
臺大學術典藏 2018-09-10T09:43:00Z Long-term regeneration and functional recovery of a 15 mm critical nerve gap bridged by tremella fuciformis polysaccharide-immobilized polylactide conduits SHAN-HUI HSU;Jiang, C.-F.;Yang, S.-H.;Weng, C.-T.;Chan, S.-H.;Hsu, S.-H.;SHAN-HUI HSU; Hsu, S.-H.; Chan, S.-H.; Weng, C.-T.; Yang, S.-H.; Jiang, C.-F.; SHAN-HUI HSU
臺大學術典藏 2018-09-10T09:20:08Z GaussSense: Attachable stylus sensing using magnetic sensor grid Liang, R.-H.; Cheng, K.-Y.; Su, C.-H.; Weng, C.-T.; Chen, B.-Y.; Yang, D.-N.; BING-YU CHEN
臺大學術典藏 2018-09-10T09:20:08Z FluxSketch: Sketching using magnetic stylus Su, C.-H.; Weng, C.-T.; Cheng, K.-Y.; Chen, B.-Y.; Yang, D.-N.; BING-YU CHEN; Liang, R.-H.
國立成功大學 2017 Monocentric experience of the rituximab therapy in systemic lupus erythematosus-associated antiphospholipid syndrome with warfarin therapy failure Wang, C.-R.;Weng, C.-T.;Liu, M.-F.
國立成功大學 2014-06 INHIBITION OF COLLAGEN-INDUCED ARTHRITIS IN RATS BY INTRA-ARTICULAR INJECTION WITH AN INHIBITOR OF THE TYROSINE KINASE EPIDERMAL GROWTH FACTOR RECEPTOR Wang, C.-R.; Chen, S.-Y.; Shiau, A.-L.; Li, Y.-T.; Weng, C.-T; Jou, I. -M.; Liu, M.-F.; Wu, C.-L.

顯示項目 1-10 / 15 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目